Edition:
United States

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

17.67USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$17.67
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
721,120
52-wk High
$41.20
52-wk Low
$14.52

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 48.87 -0.435
FY 2017 Dec '17 43.56 0.000
Sep '17 35.58 -0.533
Jun '17 30.48 -0.552
Mar '17 15.29 -0.722
FY 2016 Dec '16 11.96 -0.649
Sep '16 5.27 -0.609
Jun '16 0.10 -0.629
Mar '16 0.00 -0.447
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 7 59.24 60.30 57.00 41.96
Quarter Ending Sep-18 7 70.81 73.93 66.00 47.30
Year Ending Dec-18 7 261.41 271.60 254.87 224.27
Year Ending Dec-19 8 421.44 466.27 311.00 422.35
Earnings (per share)
Quarter Ending Jun-18 7 -0.45 -0.41 -0.47 -0.57
Quarter Ending Sep-18 7 -0.40 -0.34 -0.45 -0.54
Year Ending Dec-18 7 -1.67 -1.50 -1.97 -2.04
Year Ending Dec-19 8 -0.66 -0.21 -1.11 -0.76
LT Growth Rate (%) 1 38.30 38.30 38.30 28.90
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 222.84 32.59
P/E High - Last 5 Yrs. -- 281.48 47.07
P/E Low - Last 5 Yrs. -- 95.47 24.59
Beta 3.37 0.75 0.79
Price to Sales (TTM) 14.18 262.06 9.01
Price to Book (MRQ) 7.25 23.14 4.24
Price to Tangible Book (MRQ) 7.51 26.27 5.79
Price to Cash Flow (TTM) -- 127.68 21.78
% Owned Institutions -- 10.94 2.43

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.66
Dividend Yield - 5 Year Avg -- 0.21 0.80
Dividend 5 Year Growth Rate -- 2.35 4.15
Payout Ratio(TTM) -- 46.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 219.69 26.86 5.10
Sales (TTM) vs TTM 1 Yr. Ago 385.95 150.04 12.65
Sales - 5 Yr. Growth Rate 91.05 30.10 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 39.71 -158.81 33.25
EPS (TTM) vs TTM 1 Yr. Ago 41.76 -- --
EPS - 5 Yr. Growth Rate -- 46.66 8.54
Capital Spending - 5 Yr. Growth Rate -- 38.70 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 7.26 1.64 2.50
Current Ratio (MRQ) 7.38 6.54 3.56
LT Debt to Equity (MRQ) 0.00 22.23 12.86
Total Debt to Equity (MRQ) 0.00 25.74 15.83
Interest Coverage (TTM) -- -177.44 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 94.34 33.95 54.64
Gross Margin - 5 Yr. Avg. -- 54.86 52.74
EBITD Margin (TTM) -161.27 -- --
EBITD - 5 Yr. Avg -596.20 -158.47 15.84
Operating Margin (TTM) -163.06 -930.08 -2.34
Operating Margin - 5 Yr. Avg. -600.01 -171.29 11.09
Pre-Tax Margin (TTM) -160.33 -814.97 -0.23
Pre-Tax Margin - 5 Yr. Avg. -594.10 -176.85 11.29
Net Profit Margin (TTM) -117.97 -806.24 -3.64
Net Profit Margin - 5 Yr. Avg. -548.05 -176.13 7.58
Effective Tax Rate (TTM) -- 14.58 31.25
Effective Tax Rate - 5 Yr. Avg. -- 18.23 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 372,901 21,442,083 721,262,098
Net Income/Employee (TTM) -439,922 -1,504,037 83,813,821
Receivable Turnover (TTM) 10.53 16.37 5.67
Inventory Turnover (TTM) 1.89 2.46 3.55
Asset Turnover (TTM) 0.37 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -43.78 -5.46 9.98
Return on Assets - 5 Yr. Avg. -50.95 -0.52 11.07
Return on Investment (TTM) -49.03 -7.75 12.60
Return on Investment - 5 Yr. Avg. -55.04 2.72 14.34
Return on Equity (TTM) -49.09 -10.55 14.49
Return on Equity - 5 Yr. Avg. -55.41 -2.70 15.71
  1 Year 3 Year 5 Year
Sales % 620.68 913.43 91.05
EPS (TTM) % 23.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ACADIA Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.30 -13.33 15 40
13 Week -42.85 -42.87 7 45
26 Week -36.21 -39.73 14 84
52 Week -36.55 -44.71 27 83
YTD -41.32 -42.59 11 81
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 299
Total Shares Held: 129,588,682
3 Mo. Net Change: 4,664,045
# New Positions: 30
# Closed Positions: 40
# Increased Positions: 120
# Reduced Positions: 127
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.